Rejoinder to commentary by Drs. Boaz Musafia and Gilad Rosenberg.

Autor: Pan PY; Department of Women's and Children's Health, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Stockholm, Sweden., Cortese S; Faculty of Environmental and Life Sciences & Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, Centre for Innovation in Mental Health, School of Psychology, University of Southampton, Southampton, UK.; Solent NHS Trust, Southampton, UK.; Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK.; Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, New York, USA., Bölte S; Department of Women's and Children's Health, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Stockholm, Sweden.; Child and Adolescent Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.; Curtin Autism Research Group, Curtin School of Allied Health, Curtin University, Perth, Western Australia.

Publikováno v: Psychological medicine [Psychol Med] 2023 Jul; Vol. 53 (9), pp. 4286-4287. Date of Electronic Publication: 2022 Jan 11.

Rejoinder to commentary by Drs. Boaz Musafia and Gilad Rosenberg

Autor: Samuele Cortese, Sven Bölte, Pei-Yin Pan

Publikováno v: Psychological Medicine. :1-2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2991295f19aeb24a4e81aa24dda81e3
https://doi.org/10.1017/s0033291721005298

Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction.

Autor: Boaz Musafia, Rony Oren-Banaroya, Silvia Noiman

Publikováno v: PLoS ONE, Vol 9, Iss 5, p e97696 (2014)

This study describes the development of aptamers as a therapy against influenza virus infection. Aptamers are oligonucleotides (like ssDNA or RNA) that are capable of binding to a variety of molecular targets with high affinity and specificity. We ha

Externí odkaz: https://doaj.org/article/2b4c40e70d47467ba61c990a90c32a82

Designing Anti-Influenza Aptamers: Novel Quantitative Structure Activity Relationship Approach Gives Insights into Aptamer – Virus Interaction

Autor: Silvia Noiman, Boaz Musafia, Rony Oren-Banaroya

Publikováno v: PLoS ONE
PLoS ONE, Vol 9, Iss 5, p e97696 (2014)

This study describes the development of aptamers as a therapy against influenza virus infection. Aptamers are oligonucleotides (like ssDNA or RNA) that are capable of binding to a variety of molecular targets with high affinity and specificity. We ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa274b5d459a849a3d21591b7aacd154
http://europepmc.org/articles/PMC4028238

Complex Salt Bridges in Proteins: Statistical Analysis of Structure and Function

Autor: Dorit Arad, Boaz Musafia, Virginia Buchner

Publikováno v: Journal of Molecular Biology. 254:761-770

We developed an algorithm to analyze the distribution and geometry of simple and complex salt bridges in 94 proteins selected from the Protein Data Bank. In this study, the term "salt bridging" denotes both non-bonded and hydrogen-bonded paired elect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c76c85c6e44d81ff1f3b5149b41362f
https://doi.org/10.1006/jmbi.1995.0653